The results also showed that the down-regulation of miR-155 mediated by anti-miR-155 induced further apoptosis than the control group in CD34+ CML cells which is consistent with the oncogenic function of miR-155 in leukemia stem cells. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.